MUTE TO GO ON SALE IN WALGREENS AND DUANE READE STORES IN USA
29th March 2016. Melbourne, Australia.
Australian nasal and respiratory technology company Rhinomed Ltd (ASX:RNO), is pleased to announce the launch of its MUTE snoring and sleep technology through a 107 store promotional program in the New York- based Duane Reade chain of drug stores. Additionally, Mute will be offered for sale in 891 Walgreens stores across the USA.
The program will see all four MUTE packs (trial, small, medium and large) available in a 24 unit in-store display during a 90-day promotional program in 107 Duane Reade stores in Manhattan, New York. This launch will be accompanied by a New York-based marketing campaign commencing in late April.
Additionally, all four MUTE packs (trial pack, small, medium and large) will be offered for sale in 891 Walgreen stores across the continental USA. Both the promotional program and the roll out will commence in late April 2016. An initial order has been received for delivery of 22,500 packs of Mute.
Walgreens (www.walgreens.com), one of the USA’s largest drug store chains, is part of the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), the first global pharmacy-led, health and wellbeing enterprise. More than 8 million customers interact with Walgreens each day in communities across America, using the most convenient, multichannel access to consumer goods and services and trusted, cost- effective pharmacy, health and wellness services and advice. Walgreens operates 8,173 drug stores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. Walgreens digital business includes Walgreens.com, drugstore.com, Beauty.com, SkinStore.com and VisionDirect.com. Walgreens also manages more than 400 Healthcare Clinic and provider practice locations around the country.
A 2011 study (n=68,462) by the US Centre of Disease Control and Prevention identified that 48% of Americans snore. MUTE is designed to assist those who snore by stenting the nasal airway. A 2014 user trial showed that 75% of users reduced the frequency and severity of their snoring when using MUTE while 57% reported an improvement in sleep quality. According to IMS Health, global spending on sleep related products increased 8.8% annually since 2008 with the market reaching US$32 billon annually in 2012.